Download Medical Notes on Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review Medical Notes

About This Presentation

Description:The year 2019 was a good year for biopharma, fueled by strong fourth quarter markets and deal making. After difficult 2018, the biopharma industry recovered commendably to do good in the year 2019. A fourth-quarter surge on the stock markets meant that many biopharma companies concluded the year on a good note, as investors ran to drug developers of all sizes. As far as medtech is concerned, with rise in big- and mid-cap share prices outpaced many best companies in biopharma. However, fourth quarter was difficult for medtech with IPO numbers declining and fewer FDA approvals. This made it a mixed year for the medtech sector. Download and check this Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review to understand which areas are doing good and which are struggling, as well as what this means for biotech and medtech in 2020.

Tags:Pharma, Biotech, Medtech, pharmaceutical, biopharma

Published on: Jun 29, 2020 | Views : 1776 | Downloads : 1

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

2020 US and global life sciences outlook

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

2020 US and global life sciences outlook

Generic Drug Program Update

Drug Payment Methodologies

Rare Diseases and the Orphan Drug Act in the US

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 3

Understanding Neuromuscular Disease Care Current State and Future Prospects

Emerging Biopharma’s Contribution to Innovation

Indian API (Active Pharmaceutical Ingredient) Industry - Reaching The Full Potential

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 1

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

HEALTH A TO Z